DrugPatentWatch reports that the drug Orenitram, marketed by United Therap and available from one supplier, is protected by fourteen patents and has two Paragraph IV challenges. The generic ingredient in Orenitram is treprostinil diolamine. This drug has 59 patent family members in eight countries.
How health systems are future-proofing supply chains
Hospital supply chain leaders are calling for strategies to future-proof supply operations, reduce uncertainty and protect patient care amid rising costs. Here are responses from
